Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 05/9/17 → 03/8/21 |
Funding
- Alkermes Incorporated: $26,408.12
A Phase 3 Study in Subjects with Relapsing Remitting Multiple Sclerosis to Evaluate the Tolerability of ALKS 8700 and Dimethyl Fumarate
- Coyle, Patricia K (PI)
- McLinskey, Nancy (CoPI)
- Melville, Patricia (CoPI)
Project: Research